ClinicalTrials.govpublic full text
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies
lymphoma, non-hodgkin, lymphoma, large b-cell, diffuse, lymphoma, follicular, jcar017, b-cell malignancies, nhl, non-hodgkin lymphoma, car t cells, chimeric antigen receptor, cc-220, ibrutinib, relatlimab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 898600
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.